137 related articles for article (PubMed ID: 30268445)
21. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
[TBL] [Abstract][Full Text] [Related]
22. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
23. [Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
Liu B; Wu N; Shen Q; Shi SS; Zhang SS; Ru Y; Rao Q; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):603-608. PubMed ID: 30107665
[No Abstract] [Full Text] [Related]
24. Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
Rozenblum AB; Ilouze M; Dudnik E; Dvir A; Soussan-Gutman L; Geva S; Peled N
J Thorac Oncol; 2017 Feb; 12(2):258-268. PubMed ID: 27865871
[TBL] [Abstract][Full Text] [Related]
25. Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.
Zhang S; Yin H; Zhang J; Yang L; Yang G; Jia J; Jiao Y; Ying J; Wang Y
Thorac Cancer; 2021 Oct; 12(20):2789-2795. PubMed ID: 34464028
[TBL] [Abstract][Full Text] [Related]
26. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
Han JY; Kim SH; Lee YS; Lee SY; Hwang JA; Kim JY; Yoon SJ; Lee GK
Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
[TBL] [Abstract][Full Text] [Related]
27. Next-Generation Sequencing in Salivary Gland Basal Cell Adenocarcinoma and Basal Cell Adenoma.
Wilson TC; Ma D; Tilak A; Tesdahl B; Robinson RA
Head Neck Pathol; 2016 Dec; 10(4):494-500. PubMed ID: 27224988
[TBL] [Abstract][Full Text] [Related]
28. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathologic and molecular characterizations of Sertoli cell tumor, not otherwise specified of the testis].
Zhao M; Zhao DH; He HY; Zhang X; Ru GQ; He XL; Wang Z; Teng XD
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):505-510. PubMed ID: 29996314
[No Abstract] [Full Text] [Related]
30. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
[TBL] [Abstract][Full Text] [Related]
31. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
[TBL] [Abstract][Full Text] [Related]
32. Well-differentiated fetal adenocarcinoma of the lung: positron emission tomography features and diagnostic difficulties in frozen section analysis-a case report.
Hakiri S; Fukui T; Tsubouchi H; Sakakibara A; Iwano S; Chen-Yoshikawa TF
Surg Case Rep; 2020 Jun; 6(1):152. PubMed ID: 32601771
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel mutations in FFPE lung adenocarcinomas using DEPArray sorting technology and next-generation sequencing.
Lee JW; Shin JY; Seo JS
J Appl Genet; 2018 Aug; 59(3):269-277. PubMed ID: 29525983
[TBL] [Abstract][Full Text] [Related]
35. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V
Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750
[TBL] [Abstract][Full Text] [Related]
36. Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Wada J; Urabe S; Hirano T; Kawano K; Suzuki M; Yokoyama S; Daa T
Diagn Pathol; 2018 Jul; 13(1):48. PubMed ID: 30053869
[TBL] [Abstract][Full Text] [Related]
37. ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
Dacic S; Villaruz LC; Abberbock S; Mahaffey A; Incharoen P; Nikiforova MN
Oncotarget; 2016 Dec; 7(50):82943-82952. PubMed ID: 27769042
[TBL] [Abstract][Full Text] [Related]
38. Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment.
Cernomaz AT; Macovei II; Pavel I; Grigoriu C; Marinca M; Baty F; Peter S; Zonda R; Brutsche M; Grigoriu B
BMC Pulm Med; 2016 May; 16(1):88. PubMed ID: 27215400
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China.
Cai Y; Li H; Zhang Y
Urology; 2017 Mar; 101():170.e1-170.e7. PubMed ID: 28065512
[TBL] [Abstract][Full Text] [Related]
40. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
